COVID CommUNITY - First Nations Investigating Vaccine Access, Immunogenicity, Effectiveness and Safety among High-Risk Populations (First Nations) [Funder: PHRI]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Other Funders (Canada)
  • Principal Investigator

    Sonia and Shrikant and Russell and Dipika and Jodi Anand and Bangdiwala and De Souza and Desai and Miller
  • Research Location

    Canada
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Indigenous People

  • Occupations of Interest

    Unspecified

Abstract

The COVID CommUNITY - First Nations study is being conducted to understand the immune response and safety of the COVID-19 vaccine in First Nations people who have been disproportionately affected by the pandemic, and have worse outcomes from COVID-19 infection compared to other groups. The study also aims to understand why some people are not as confident in the COVID-19 vaccine as others, and to document the overall impact of COVID-19 in these communities. The study will also provide insight into how a pandemic of this scale can be prevented in these communities and other vulnerable populations. Participants for the study are being recruited from First Nations communities: i From vaccination or assessment centres and; ii By re-contacting participants (18+) from our on-going prospective cohort studies via telephone/email. Dried blood spots for assessment of antibodies to COVID vaccination are being assessed from all participants.